Deep convolutional neural network-based algorithm for muscle biopsy diagnosis.

Journal: Laboratory investigation; a journal of technical methods and pathology
PMID:

Abstract

Histopathologic evaluation of muscle biopsy samples is essential for classifying and diagnosing muscle diseases. However, the numbers of experienced specialists and pathologists are limited. Although new technologies such as artificial intelligence are expected to improve medical reach, their use with rare diseases, such as muscle diseases, is challenging because of the limited availability of training datasets. To address this gap, we developed an algorithm based on deep convolutional neural networks (CNNs) and collected 4041 microscopic images of 1400 hematoxylin-and-eosin-stained pathology slides stored in the National Center of Neurology and Psychiatry for training CNNs. Our trained algorithm differentiated idiopathic inflammatory myopathies (mostly treatable) from hereditary muscle diseases (mostly non-treatable) with an area under the curve (AUC) of 0.996 and achieved better sensitivity and specificity than the diagnoses done by nine physicians under limited diseases and conditions. Furthermore, it successfully and accurately classified four subtypes of the idiopathic inflammatory myopathies with an average AUC of 0.958 and classified seven subtypes of hereditary muscle disease with an average AUC of 0.936. We also established a method to validate the similarity between the predictions made by the algorithm and the seven physicians using visualization technology and clarified the validity of the predictions. These results support the reliability of the algorithm and suggest that our algorithm has the potential to be used straightforwardly in a clinical setting.

Authors

  • Yoshinori Kabeya
    Healthcare Analytics, Global Business Services, IBM Japan Ltd, Tokyo, Japan.
  • Mariko Okubo
    Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Sho Yonezawa
    Healthcare Analytics, Global Business Services, IBM Japan Ltd, Tokyo, Japan.
  • Hiroki Nakano
    Healthcare Analytics, Global Business Services, IBM Japan Ltd, Tokyo, Japan.
  • Michio Inoue
    Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Masashi Ogasawara
    Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Yoshihiko Saito
    Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Jantima Tanboon
    Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Luh Ari Indrawati
    Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Theerawat Kumutpongpanich
    Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Yen-Lin Chen
    Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Wakako Yoshioka
    Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Shinichiro Hayashi
    Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Toshiya Iwamori
    IBM Research-Tokyo, Japan.
  • Yusuke Takeuchi
    Watson Health, IBM Corporation, New York, NY, USA.
  • Reitaro Tokumasu
    IBM Japan Ltd., Tokyo, Japan.
  • Atsushi Takano
    IBM Japan Ltd., Tokyo, Japan.
  • Fumihiko Matsuda
    Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Ichizo Nishino
    Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan. nishino@ncnp.go.jp.